Charmin Gohel, MD
Pediatrics · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Gohel’s office at (888) 926-9385 to ask if they take your plan before you enroll.
California Medical Board record
Licence A158888 · Current
Licensed to practise in California · since 2018 · expires 2026-10-31 · Maharashtra University of Health Services, Topiwala National Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$497,113 in 2024
Medicaid paid $497,113 for 7,519 billed services this clinician did in 2024, up to 315 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,363 | $479,303 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 482 | $9,270 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 541 | $4,059 |
| Short return visit (20+ min) | 1,421 | $2,199 |
| Short return visit | 891 | $1,047 |
| Bilateral quantitative screening test of visual acuity | 171 | $524 |
| HEMOGLOBIN | 187 | $387 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 467 | $224 |
| Screening test, pure tone, air only | 165 | $56 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 188 | $44 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 45 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 54 | $0 |
| 2024 | 7,519 | 19 | 315 | $497,113 |
| 2023 | 9,113 | 20 | 301 | $629,716 |
| 2022 | 5,110 | 17 | 338 | $334,337 |
| 2021 | 10,301 | 21 | 329 | $707,626 |
| 2020 | 15,549 | 25 | 355 | $686,672 |
| 2019 | 3,876 | 19 | 293 | $163,153 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 3,065 | $611,981 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 505 | $9,882 |
| Short return visit (20+ min) | 1,762 | $2,380 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 450 | $2,151 |
| Short return visit | 1,307 | $1,501 |
| Bilateral quantitative screening test of visual acuity | 237 | $739 |
| HEMOGLOBIN | 241 | $499 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 76 | $235 |
| Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | 13 | $128 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 29 | $91 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 517 | $75 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 34 | $33 |
2022
| Clinic visit/encounter, all-inclusive | 1,644 | $321,854 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 413 | $8,460 |
| Short return visit | 1,114 | $1,916 |
| Short return visit (20+ min) | 658 | $1,021 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 205 | $382 |
| Bilateral quantitative screening test of visual acuity | 109 | $357 |
| HEMOGLOBIN | 137 | $273 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 253 | $75 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 19 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 33 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 76 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 134 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 3,863 | $683,449 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 788 | $14,562 |
| Short return visit | 2,510 | $3,850 |
| Short return visit (20+ min) | 985 | $2,382 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 439 | $2,047 |
| Bilateral quantitative screening test of visual acuity | 174 | $554 |
| New patient visit (30+ min) | 89 | $499 |
| HEMOGLOBIN | 130 | $219 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 384 | $37 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 127 | $9 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 168 | $9 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 98 | $9 |
2020
| Clinic visit/encounter, all-inclusive | 4,760 | $667,926 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 1,458 | $10,993 |
| Short return visit | 2,825 | $3,965 |
| Short return visit (20+ min) | 1,667 | $1,257 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 436 | $1,145 |
| Bilateral quantitative screening test of visual acuity | 525 | $625 |
| HEMOGLOBIN | 550 | $368 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 399 | $224 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 184 | $88 |
| Screening test, pure tone, air only | 585 | $45 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 339 | $18 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 371 | $18 |
2019
| Clinic visit/encounter, all-inclusive | 1,219 | $162,706 |
| Short return visit (20+ min) | 677 | $413 |
| Screening test, pure tone, air only | 218 | $11 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 87 | $9 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 312 | $9 |
| Bilateral quantitative screening test of visual acuity | 186 | $3 |
| HEMOGLOBIN | 270 | $2 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 476 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 65 | $0 |
| Immunization administration by intranasal or oral route; each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 12 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 43 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 24 | $0 |
Money from drug and device companies
$156 in 2025
A payment is not proof that care is biased.
| Boston Scientific | General - Pain Management | $131 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $25 | 1 payment
|
See all 2 published payments
| Boston Scientific | Meals · 2025-10-29 | General - Pain Management | $131 |
| Dexcom | Meals · 2025-05-07 | Dexcom G6 Transmitter | $25 |
Professional record
- NPI
- 1144773037
- Licence
- CA A158888California A158888: Current · expires 2026-10-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 350 Potrero Ave, Sunnyvale, CA, 94085
- NPI first listed
- 2016-07-27
- NPI last updated
- 2025-03-03
- NPI record certified
- 2025-03-03
This is when the NPI record was last certified, not a medical board exam.